Independent Prognostic Factors for Fatality in Patients with Urinary Tract Infection Caused by Serratia marcescens

Infection Control and Hospital Epidemiology

Volumn 25, Issue 1, 2004, Pages 80-82

  Liu, Jien Wei ^a,b   Hsu, Yu Mai ^b   Huang, Yen Fen ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CEFALOTIN; CEFTAZIDIME; CEFTIZOXIME; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NITROFURANTOIN; PIPERACILLIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CATHETERIZATION; FATALITY; FEMALE; GENDER; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SERRATIA MARCESCENS; URINARY TRACT INFECTION; UROLOGICAL PROCEDURES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS INFECTION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SERRATIA INFECTIONS; SERRATIA MARCESCENS; TAIWAN; URINARY TRACT INFECTIONS;

EID: 0942266167     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502297     Document Type: Article

References (14)

1. Maki DG, Hennekens CG, Phillips CW, Shaw WV, Bennett JV. Nosocomial urinary tract infection with Serratia marcescens: an epidemiologic study. J Infect Dis 1973;128:579-587.
2. Rutala WA, Kennedy VA, Loflin HB, Sarubbi FA Jr. Serratia marcescens nosocomial infection of the urinary tract associated with urine measuring containers and urinometers. Am J Med 1981;70:659-663.
3. van der Sar-van der Brugge S, Arend SM, Bernards AT, et al. Risk factors for acquisition of Serratia marcescens in a surgical intensive care unit. J Hosp Infect 1999;41:291-299.
4. Garibaldi RA, Burke JP, Dickman ML, Smith CB. Factors predisposing to bacteriuria during indwelling urethral catheterization. N Engl J Med 1974;291:215-219.
5. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infection, 1988. Am J Infect Control 1988;16:128-140.
6. Holt JG, Krieg NR, Sneath PHA, Staley JT, Williams ST. Bergey's Manual of Determinative Bacteriology, ed. 9. Baltimore, MD: Williams & Wilkins; 1997:243-245.
7. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests, ed. 6. Villanova, PA: National Committee for Clinical Laboratory Standards; 1997. Approved standard M2-A6.
8. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
9. Stamm WE, Martin SM, Bennett JV. Epidemiology of nosocomial infections due to gram-negative bacilli: aspects relevant to development and use of vaccines. J Infect Dis 1977;136(suppl):S151-S160.
10. Krieger JN, Kaiser DL, Wenzel RP. Urinary tract etiology of bloodstream infections in hospitalized patients. J Infect Dis 1983;148:57-62.
11. Saito H, Elting L, Bodey GP, Berkey P. Serratia bacteremia: review of 118 cases. Rev Infect Dis 1989;11:912-920.
12. Eisenstein BI, Zaleznik DF. Enterobacteriaceae. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, ed. 5. Philadelphia: Churchill Livingstone; 2000:2294-2310.
13. Yu VL. Serratia marcescens: historical perspective and clinical review. N Engl J Med 1979;300:887-893.
14. Warren JW, Tenney JH, Hoopes JM, Muncie HL, Anthony WC. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis 1982;146:719-723.